Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
810.00    2.00 (0.25%)
Bid:
810.00
Ask:
811.00
Spread: 1.00 (0.123%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2019 10:04

RNS Number : 3697Y
Savills PLC
08 May 2019
 

 

8 May 2019

SAVILLS PLC

("Savills" or "the Company")

AGM Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date the Group has traded in line with our expectations. Globally, our transaction businesses have continued to maintain strong market shares although, as anticipated, volumes in certain markets have been subdued as a result of political and economic uncertainty. Our Consultancy, Property Management and Investment Management businesses have continued to perform well.

 

In the UK, trading has been resilient despite increased political uncertainty. In our Residential Transaction business there has been a healthy increase in indicators which are normally a precursor to increased market activity. Of particular note is strong double digit increases in new buyers registered and a year-on-year increase in revenue in the prime Central London market. The Commercial Transaction business is also proving resilient, particularly in Central London, however, volumes across the UK have declined and development activity is relatively subdued.

 

In Asia Pacific, Savills has had a good start to the year, with Hong Kong, Mainland China, Singapore and Vietnam showing year-on-year revenue growth.

 

In North America, the business has successfully rebranded to Savills and continued its strong revenue performance from Q4 2018 through the period, with corporates generally active in relatively benign market conditions. The New York, Washington and Californian markets have proved particularly active to date.

 

In Continental Europe and the Middle East, we have traded in line with our expectations, with good year-on-year revenue growth in Ireland, France, the Netherlands and the Czech Republic. In Sweden, the new Capital markets and leadership team have started well accumulating a strong pipeline of potential transaction activity for the second half of the year.

 

Savills Investment Management has performed as expected. As previously announced, we successfully concluded the search for a new CEO for Savills Investment Management , with Alex Jeffrey due to join the firm later in the year.

 

Whilst the year has started as expected, the first few months typically represent a relatively modest proportion of the expected outturn for the full year. In the UK market, there remains significant investor demand but commercial transaction activity in the next few months may continue to be overshadowed by the prolonged uncertainty over Brexit, the exact impact of which is difficult to determine at present. We do, however, expect some strengthening of activity in certain overseas markets and, despite a greater weighting towards H2 than last year, we continue to anticipate overall performance for 2019 to be in line with our expectations.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLIFIAELITIIA
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.